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Pulmonary Artery Compliance
A Promising Diagnostic and Prognostic Tool in Pulmonary Hypertension?*
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aPulmonary hypertension, whether caused by idio-
pathic pulmonary arterial hypertension or as a
complication of an increasingly recognized number
of primary disease states, is associated with signif-
icant mortality and morbidity (1,2). Diagnosing
pulmonary hypertension, however, may be chal-
lenging (3). Symptoms can be nonspecific and may
be attributed to the underlying disease, and unlike
blood pressure monitoring in the systemic arterial
tree, there is no simple, inexpensive test for evalu-
ating the pulmonary arteries. The widely available
See page 286
biomarker brain natriuretic peptide (BNP) is not
specific for pulmonary hypertension. Resting echo-
cardiography is limited by technical expertise in
measurement of the tricuspid regurgitant jet, pa-
tient factors such as body habitus, and cost. More-
over, it may not be sensitive enough to detect mild
pulmonary hypertension or exercise-induced pul-
monary hypertension. Right heart catheterization is
usually needed for a definitive diagnosis, but it is
invasive and provides an assessment of resting and,
at most, exercise pulmonary vascular resistance, only
one of several factors that contribute to right ven-
tricular overload. Thus, for many reasons, patients
are frequently diagnosed and treatment is initiated
only after the development of moderate or worse
symptoms and significant hemodynamic abnormal-
ities. Although there are no data about the natural
history or treatment of mild and exercise-associated
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.a
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San Diego, California.ulmonary hypertension, early treatment potentially
ould slow or prevent the progression of the disease.
widely available, noninvasive method of assessing
he pulmonary arteries to identify early disease
ould be a significant advance.
Systemic arterial vascular stiffness has been in-
ensively studied and is a known independent risk
actor for cardiac events. The pathophysiology and
linical consequences of increasing arterial stiffness
ave recently been reviewed (4). The cushion and
onduit functions of the peripheral arterial system
re finely tuned so that pulsatile blood flow becomes
onstant in organ capillaries, and reflected pressure
aves augment diastolic blood flow and myocardial
xygen delivery. With aging, structural changes in
he large arteries result in dilation and stiffening.
he cushioning function is compromised, resulting
n increasing pulse pressure. Systolic blood pressure
ncreases and reflected waves now return earlier in
ystole, thereby increasing afterload. Flow that re-
ains pulsatile at the level of the capillaries may
ause microvascular injury and end-organ damage.
lthough there are no coronary arteries to perfuse
t the junction of the right ventricle and the
ulmonary artery, the physiology of ventricular-
rterial coupling is otherwise similar in the pulmo-
ary circulation as are microvascular lesions in the
ungs and other organs when the system becomes
ysregulated.
Hemodynamic assessment of the patient with
ulmonary hypertension relies on pressures mea-
ured during right heart catheterization and the
alculated pulmonary vascular resistance. Patho-
ogic changes in the post-capillary resistance vessels
f pulmonary arteries increase right ventricular
fterload until patients present with symptoms of
nd eventually die of right-sided heart failure.
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297Resistance, however, is only one component of
afterload, capacitance and impedance being the
others. Furthermore, resistance calculations assume
a constant blood flow, whereas compliance capaci-
tance and impedance are more useful to describe
pulsatile flow. Measures of pulmonary artery stiff-
ness better reflect these latter components that
could contribute to worsening right heart failure
and pulmonary microvascular disease by the same
mechanisms that affect the left heart and systemic
circulation. Several studies have begun to measure
and explore the clinical relevance of pulmonary
artery stiffness in pulmonary hypertension.
In this issue of iJACC, Sanz et al. (5) report on
patients with known or suspected pulmonary hy-
pertension studied with same-day right heart cath-
eterization and cardiac magnetic resonance (CMR)
to characterize pulmonary artery stiffness. Of 94
patients included in the analysis, 75 had pulmonary
hypertension with a mean pulmonary artery pres-
sure of 43 mm Hg and a mean cardiac index of 3.2
l/min/m2. Thirteen had normal hemodynamics,
and 6 had exercise-induced pulmonary hyperten-
sion only. In comparison to normal subjects, every
measure of arterial stiffness (pulsatility, compliance,
capacitance, distensibility, elastic modulus, and
stiffness index) was significantly worse in patients
with pulmonary hypertension. In patients with
exercise-induced pulmonary hypertension, compli-
ance and capacitance were significantly worse than
in normal subjects. Statistically significant correla-
tions were shown between mean pulmonary artery
pressure and pulmonary vascular resistance versus
all measures of arterial stiffness with the exception
of the stiffness index, .
The work by Sanz et al. (5) complements and
extends other investigations about the significance of
pulmonary artery stiffness. Three recent studies that
have found that increased pulmonary artery stiffness is
associated with increased mortality (6–8). Rodes-
Cabau et al. (6) showed intravascular ultrasound mea-
surement of decreased pulsatility in distal pulmonary
arteries of 20 patients was associated with a higher
12-month mortality. Another study showed that pul-
monary arteriolar capacitance measured during right
heart catheterization in 104 patients was a better
predictor of mortality than 6-min walk distance,
cardiac index, right atrial pressure, pulmonary vascular
resistance, and National Institutes of Health 4-year
predicted survival equation (7). In another study of 70
patients and 16 control subjects followed up over 48
months, CMR measured changes in relative cross-
sectional area of the proximal vessel was a bettermarker of death than 6-min walk distance, pulmonary
vascular resistance, or right atrial pressure (8).
The study by Sanz et al. (5) adds to these by
providing same-day invasive hemodynamic data
and CMR imaging and by showing the graded
relationship between severity of hemodynamic find-
ings and severity of changes in pulmonary artery
stiffness. The study further reinforces the possible
pathophysiologic importance of pulmonary artery
stiffness and raises a new possibility: that the assess-
ment of pulmonary artery stiffness could lead to
early diagnosis of pulmonary hypertension.
It seems then that conventional assessment of the
pulmonary vascular system and right heart with
echocardiography and right heart catheterization
are not telling the whole story. Worsening pulmo-
nary arterial stiffness may be among the first patho-
physiologic manifestations of pulmonary hyperten-
sion before pressure or resistance begins to increase.
In a large cohort of patients with variable degrees of
pulmonary hypertension, Sanz et al. (5) show a
curvilinear relationship between measures of pul-
monary artery stiffness and systolic pulmonary ar-
tery pressure. Pulmonary artery stiffness was mark-
edly increased in patients with even mild increases
in pulmonary artery pressure. Pulmonary artery
stiffness was markedly abnormal but quite similar
over a range of elevated pulmonary artery pressures.
Furthermore, although hemodynamics in patients
with exercise-induced pulmonary hypertension
were not significantly different than those for con-
trols, stiffness was significantly worse. Lankhaar et
al. (9) reported findings in a smaller cohort of
patients for whom longitudinal data were available
showing a similar relationship between capacitance
and pulmonary vascular resistance. The product of
capacitance and resistance was constant over time,
supporting the notion of progression along the
curve with stiffness worsening before resistance
increasing. Pulmonary artery stiffness may contrib-
ute to the disconnect between the severity of he-
modynamic abnormalities and treatment response
to vasodilator drugs (1).
A compelling clinical application of pulmonary
artery stiffness assessed by CMR could be the early
detection of pulmonary hypertension among pa-
tients at elevated risk for the disease. Further study
is required to examine the natural history of
exercise-induced and mild pulmonary hypertension,
but it seems likely that patients with advanced
pulmonary hypertension at some time may have had
early disease characterized by mildly abnormal he-
modynamic alterations (10). It also is reasonable to
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 3 , 2 0 0 9
M A R C H 2 0 0 9 : 2 9 6 – 8
Ben-Yehuda and Barnett
Editorial Comment
298hypothesize that treatment at an early stage of the
disease, before the development of significant he-
modynamic compromise, could alter the natural
history and disease progression leading to an im-
provement in morbidity and mortality.
The main limitations of the study by Sanz et al.
(5) are the small number of patients with exercise-
induced hypertension, a particularly important
group in which there are insufficient data regarding
prognosis and treatment. In addition, although
noninvasive and not requiring exercise, CMR is still
an expensive and technically challenging test. Its
routine clinical application in the assessment of2007;50:1–13. nary artery stiffnessThe study by Sanz et al. (5) represents a signif-
icant contribution to the growing body of literature
showing the importance of pulmonary artery stiff-
ness in pulmonary hypertension. Larger prospective
trials that assess whether increased pulmonary artery
stiffness as detected by CMR, particularly in exercise-
induced pulmonary hypertension, predicts develop-
ment of resting pulmonary hypertension will be nec-
essary. If validated, it could provide an important tool
in both research and clinical practice.
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